FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4296286712> ?p ?o ?g. }

• W4296286712 abstract "Ginkgo biloba has gained increasing attention owing to its remarkable effects against cardiovascular disease. However, the role of G. biloba in hepatic lipid metabolism disorders in type 2 diabetes mellitus (T2DM) combined with non-alcoholic fatty liver disease (NAFLD) and its underlying mechanisms have not been elucidated. Here, the effective ingredients and mechanisms of action of G. biloba in T2DM combined with NAFLD were investigated via an integrated strategy of network pharmacology and molecular docking. Thirty-four core targets for the alleviation of T2DM combined with NAFLD were identified and retrieved from multiple open-source databases, after validating the ameliorative effect of G. biloba on lipid accumulation in vitro. The targets IL6, IL1B, VEGFA, PTGS2, and CCL2, among others, with high network association values, were screened using Cytoscape. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analysis showed that 34 compounds derived from G. biloba may exert therapeutic effects via response to molecule of bacterial origin, cellular response to lipid, and response to the hormone. In addition, the AGE-RAGE and IL-17 signaling pathways were predicted to be most significantly affected. Meanwhile, the outcomes of the molecular docking experiment showed that the most effective ingredients in G. biloba showed a strong binding affinity to the potential target active sites. Findings from further in vitro experiments confirmed that G. biloba treatment decreased the level of IL6, IL1B, and VEGFA protein. In conclusion, our findings provided novel insights into the mechanisms underlying the therapeutic effect of G. biloba in T2DM combined with NAFLD. PRACTICAL APPLICATIONS: As a medicinal food plant, G. biloba has been shown to exert benefits in cardiovascular diseases. However, the pharmacological material basis and complex mechanism of action in G. biloba in T2DM combined with NAFLD remain unknown. Here, the mechanism by which G. biloba could ameliorate T2DM combined with NAFLD was investigated, and the potential target and molecular mechanism were explored, through a comprehensive strategy combining network pharmacology and molecular docking. Our findings indicate that G. biloba exerts synergistic effects in treating T2DM combined with NAFLD through multi-ingredients, multi-targets, and multi-pathways; the findings also elucidate the nutritional and therapeutic potential of G. biloba in preventing and treating T2DM combined with NAFLD and provides robust evidence for its clinical application." @default.
• W4296286712 created "2022-09-19" @default.
• W4296286712 creator A5034686488 @default.
• W4296286712 creator A5044162026 @default.
• W4296286712 creator A5045208180 @default.
• W4296286712 creator A5046436076 @default.
• W4296286712 creator A5046944376 @default.
• W4296286712 creator A5058486196 @default.
• W4296286712 creator A5086567390 @default.
• W4296286712 date "2022-09-19" @default.
• W4296286712 modified "2023-10-14" @default.
• W4296286712 title "Molecular mechanism of <i>Ginkgo biloba</i> in treating type 2 diabetes mellitus combined with non‐alcoholic fatty liver disease based on network pharmacology, molecular docking, and experimental evaluations" @default.
• W4296286712 cites W1080222946 @default.
• W4296286712 cites W1983110274 @default.
• W4296286712 cites W2087377825 @default.
• W4296286712 cites W2103017472 @default.
• W4296286712 cites W2103641796 @default.
• W4296286712 cites W2162382402 @default.
• W4296286712 cites W2338839662 @default.
• W4296286712 cites W2400718903 @default.
• W4296286712 cites W2501497123 @default.
• W4296286712 cites W2551202923 @default.
• W4296286712 cites W2558250647 @default.
• W4296286712 cites W2615408991 @default.
• W4296286712 cites W2799824772 @default.
• W4296286712 cites W2889932786 @default.
• W4296286712 cites W2900017146 @default.
• W4296286712 cites W2946412700 @default.
• W4296286712 cites W2955615964 @default.
• W4296286712 cites W2970026022 @default.
• W4296286712 cites W2970210473 @default.
• W4296286712 cites W2996714785 @default.
• W4296286712 cites W2997259351 @default.
• W4296286712 cites W3006556122 @default.
• W4296286712 cites W3035768631 @default.
• W4296286712 cites W3047056909 @default.
• W4296286712 cites W3054641875 @default.
• W4296286712 cites W3094841061 @default.
• W4296286712 cites W3095024133 @default.
• W4296286712 cites W3152380819 @default.
• W4296286712 cites W3163475530 @default.
• W4296286712 cites W3186727087 @default.
• W4296286712 cites W3194808394 @default.
• W4296286712 cites W3198005949 @default.
• W4296286712 cites W3212896804 @default.
• W4296286712 cites W3214232253 @default.
• W4296286712 cites W3215127728 @default.
• W4296286712 cites W4205408617 @default.
• W4296286712 cites W4211038909 @default.
• W4296286712 cites W4212861428 @default.
• W4296286712 cites W4220847554 @default.
• W4296286712 cites W4220953887 @default.
• W4296286712 cites W4221022104 @default.
• W4296286712 cites W4221121824 @default.
• W4296286712 cites W4221134807 @default.
• W4296286712 cites W4280514619 @default.
• W4296286712 cites W4281928796 @default.
• W4296286712 cites W4282915951 @default.
• W4296286712 cites W4286215644 @default.
• W4296286712 cites W628038580 @default.
• W4296286712 cites W2966694182 @default.
• W4296286712 doi "https://doi.org/10.1111/jfbc.14419" @default.
• W4296286712 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36121703" @default.
• W4296286712 hasPublicationYear "2022" @default.
• W4296286712 type Work @default.
• W4296286712 citedByCount "2" @default.
• W4296286712 countsByYear W42962867122023 @default.
• W4296286712 crossrefType "journal-article" @default.
• W4296286712 hasAuthorship W4296286712A5034686488 @default.
• W4296286712 hasAuthorship W4296286712A5044162026 @default.
• W4296286712 hasAuthorship W4296286712A5045208180 @default.
• W4296286712 hasAuthorship W4296286712A5046436076 @default.
• W4296286712 hasAuthorship W4296286712A5046944376 @default.
• W4296286712 hasAuthorship W4296286712A5058486196 @default.
• W4296286712 hasAuthorship W4296286712A5086567390 @default.
• W4296286712 hasBestOaLocation W42962867121 @default.
• W4296286712 hasConcept C126322002 @default.
• W4296286712 hasConcept C134018914 @default.
• W4296286712 hasConcept C2778772119 @default.
• W4296286712 hasConcept C2778998842 @default.
• W4296286712 hasConcept C2779134260 @default.
• W4296286712 hasConcept C2910068830 @default.
• W4296286712 hasConcept C4733338 @default.
• W4296286712 hasConcept C55493867 @default.
• W4296286712 hasConcept C555293320 @default.
• W4296286712 hasConcept C60644358 @default.
• W4296286712 hasConcept C71924100 @default.
• W4296286712 hasConcept C86803240 @default.
• W4296286712 hasConcept C98274493 @default.
• W4296286712 hasConceptScore W4296286712C126322002 @default.
• W4296286712 hasConceptScore W4296286712C134018914 @default.
• W4296286712 hasConceptScore W4296286712C2778772119 @default.
• W4296286712 hasConceptScore W4296286712C2778998842 @default.
• W4296286712 hasConceptScore W4296286712C2779134260 @default.
• W4296286712 hasConceptScore W4296286712C2910068830 @default.
• W4296286712 hasConceptScore W4296286712C4733338 @default.
• W4296286712 hasConceptScore W4296286712C55493867 @default.
• W4296286712 hasConceptScore W4296286712C555293320 @default.
• W4296286712 hasConceptScore W4296286712C60644358 @default.
• W4296286712 hasConceptScore W4296286712C71924100 @default.

• next